Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Balaji Srinivasan, who may run the FDA for Trump, hates the FDA. But Silicon Valley likes Srinivasan.

Just ask Twitter.

TechCrunch Disrupt SF 2013 - Day 2
TechCrunch Disrupt SF 2013 - Day 2
Balaji Srinivasan (left) at a TechCrunch event
Steve Jennings/Getty Images for TechCrunch
Peter Kafka
Peter Kafka covered media and technology, and their intersection, at Vox. Many of his stories can be found in his Kafka on Media newsletter, and he also hosts the Recode Media podcast.

Balaji Srinivasan is a Silicon Valley entreprenuer who had a well-known penchant for mixing it up on Twitter.

Now Srinivasan is reportedly a candidate to run the Food and Drug Administration for Donald Trump. And Srinivasan is apparently done mixing it up on Twitter, which he joined in 2013: He has deleted his old tweets, and has left his 47,500 followers with a single message:

Why would Srinivasan delete his Twitter archive? It would be nice to hear from the man himself, but here’s a reasonable guess: He spent a lot of time criticizing the FDA, and he’d rather pretend those criticisms didn’t exist.

Then again, Srinivasan understands how technology works, so he certainly knows that deleting your tweets doesn’t make them disappear. You can get a sense of what Srinivasan used to tweet about by looking at this Google cache.

And you can get much more specific, courtesy of people who took screenshots of some of his tweets: In short, Srinivasan seems to think the FDA prevents drug companies and startups from innovating by imposing unnecessary regulations.

In 2014, for instance, he argued that a “Yelp for Drugs,” where doctors submitted ratings and patients relayed their experiences, would help sick people more than the FDA.

Last year, he was making the same argument, except this time he used Uber, eBay and Airbnb as his models. Sure, there’s risk involved, he said. But people like extreme sports, too: “If you can skydive or jump off a bridge, you should be free to take an experimental treatment.”

Here’s a more comprehensive archive, courtesy of Christa Peterson.

So Srinivasan seems to have the same view of the agency he might run as other Trump appointees have of the organizations they’re supposed to run: They want them to go away.

But there’s one thing that distinguishes Srinivasan from other Trump nominees: Srinivasan, who runs a Bitcoin startup and co-founded a genetic testing company, has a bunch of fans in Silicon Valley.

That starts with Trump-backer Peter Thiel, but isn’t limited to him. Here’s a Twitter testimonial from investor Ashvin Bachireddy:

And another one from investor Naval Ravikant (that’s Ravikant sitting next to Srinivasan at a 2013 TechCrunch event in the photo at the top of this post):

Seconded by Dilbert creator and Trump fan Scott Adams (really):

And here’s the finale: A blessing from Andreessen Horowitz co-founder Ben Horowitz:

Horowitz’s endorsement of Srinivasan isn’t a shock, since Srinivasan is a board partner at Andreessen Horowitz, which means Srinivasan helps the influential VC firm source deals, and sometimes takes a board seat at some of its portfolio companies.

Still, it’s worth noting: Up until now, tech leaders have been unwilling to endorse any part of the Trump agenda in public.

Srinivasan isn’t formally part of the Trump agenda yet. But you can see how if he gets there, Techland — at least corners of it — could start telling itself that Trumpland might have some upside, after all. They might even start saying it out loud.

Correction: An earlier version of this story incorrectly named the creator of the Dilbert comic strip.


This article originally appeared on Recode.net.

See More:

More in Technology

Podcasts
Could you spot an AI-written book?Could you spot an AI-written book?
Podcast
Podcasts

An author set up an experiment to find out.

By Amina Al-Sadi and Noel King
Future Perfect
The 5 most unhinged revelations from Elon Musk’s lawsuit against OpenAIThe 5 most unhinged revelations from Elon Musk’s lawsuit against OpenAI
Future Perfect

The Musk v. OpenAI trial is over. Here are the receipts.

By Sara Herschander
Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North